Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles
National University of Singapore
Indexed incrossrefpubmed
Abstract
Red blood cells (RBCs) and RBC membrane-derived nanoparticles have been historically developed as bioinspired drug delivery systems to combat the issues of premature clearance, toxicity, and immunogenicity of synthetic nanocarriers. RBC-based delivery systems possess characteristics including biocompatibility, biodegradability, and long circulation time, which make them suited for systemic administration. Therefore, they have been employed in designing optimal drug formulations in various preclinical models and clinical trials to treat a wide range of diseases. In this review, we provide an overview of the biology, synthesis, and characterization of drug delivery systems based on RBCs and their membrane…
Citation impact
201
total citations
- FWCI
- 34.19
- Percentile
- 100%
- References
- 187
Citations per year
Authors
5Topics & keywords
Topics
Keywords
- Drug delivery
- Nanocarriers
- Nanotechnology
- Drug
- Biocompatibility
- Targeted drug delivery
- Nanomedicine
- Liposome
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.